Search a title or topic

Over 20 million podcasts, powered by 

Player FM logo
Artwork

Content provided by Oncolgy Times and Audio Medica. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Oncolgy Times and Audio Medica or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Oncology Times Broadcast News with the Audio Journal of Oncology - February 2009

31:26
 
Share
 

Manage episode 153458762 series 1090654
Content provided by Oncolgy Times and Audio Medica. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Oncolgy Times and Audio Medica or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.
ONCOLOGY TIMES BROADCAST NEWS WITH THE AUDIO JOURNAL OF ONCOLOGY February 2009 Peter Goodwin interviews more speakers from the 50th American Society of Hematology Annual Meeting, San Francisco, December 6-9, 2008 IN THIS EDITION: Greater Role for Umbilical Cord Blood in Adult Transplants Mary Eapen, Medical College of Wisconsin, Milwaukee COMMENT: Armand Keating, University of Toronto Ex Vivo Expansion Of Cord Blood Derived Progenitor Cells: Patient Transplant Data Colleen Delaney, Fred Hutchinson Cancer Research Center, Seattle COMMENT: Armand Keating Erythropoiesis Stimulating Agents in Cancer Patients: Meta-Analysis Mortality Findings Julia Bohlius, University of Bern ON BEHALF OF: Erythropoiesis Stimulating Agents Individual Patient Data (EPO IPD) Meta-Analysis Collaborative Group COMMENTS: Linda Burns, University of Minnesota, Minneapolis George Canellos, Dana-Farber Cancer Institute, Boston Imatinib: Durable Responses And Survival in Chronic Myeloid Leukemia: 7-Year IRIS Study Results; Can Imatinib Be Stopped? Stephen O'Brien, Newcastle University, England
  continue reading

19 episodes

Artwork
iconShare
 
Manage episode 153458762 series 1090654
Content provided by Oncolgy Times and Audio Medica. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Oncolgy Times and Audio Medica or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.
ONCOLOGY TIMES BROADCAST NEWS WITH THE AUDIO JOURNAL OF ONCOLOGY February 2009 Peter Goodwin interviews more speakers from the 50th American Society of Hematology Annual Meeting, San Francisco, December 6-9, 2008 IN THIS EDITION: Greater Role for Umbilical Cord Blood in Adult Transplants Mary Eapen, Medical College of Wisconsin, Milwaukee COMMENT: Armand Keating, University of Toronto Ex Vivo Expansion Of Cord Blood Derived Progenitor Cells: Patient Transplant Data Colleen Delaney, Fred Hutchinson Cancer Research Center, Seattle COMMENT: Armand Keating Erythropoiesis Stimulating Agents in Cancer Patients: Meta-Analysis Mortality Findings Julia Bohlius, University of Bern ON BEHALF OF: Erythropoiesis Stimulating Agents Individual Patient Data (EPO IPD) Meta-Analysis Collaborative Group COMMENTS: Linda Burns, University of Minnesota, Minneapolis George Canellos, Dana-Farber Cancer Institute, Boston Imatinib: Durable Responses And Survival in Chronic Myeloid Leukemia: 7-Year IRIS Study Results; Can Imatinib Be Stopped? Stephen O'Brien, Newcastle University, England
  continue reading

19 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Copyright 2025 | Privacy Policy | Terms of Service | | Copyright
Listen to this show while you explore
Play